Infant Formula Requirements

ICR 202209-0910-009

OMB: 0910-0256

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
ICR Details
0910-0256 202209-0910-009
Received in OIRA 202104-0910-013
HHS/FDA CFSAN
Infant Formula Requirements
Revision of a currently approved collection   No
Emergency 09/28/2022
09/28/2022
  Requested Previously Approved
6 Months From Approved 05/31/2024
8,110 7,995
132,715 128,530
0 0

This ICR supports the recordkeeping, reporting, and labeling requirements for the manufacture and distribution of infant formula. Respondents to this collection are infant formula manufacturers who must ensure that their products adhere to the quality control provisions and procedures found in FDA regulations, and that nutrient information and directions for use are disclosed in their product labeling.
FDA is submitting this request memorandum in accordance with 5 CFR 1320.13. As disruptions in the supply of infant formula continue, we are pursuing longer-term information collection pertaining to our exercise of enforcement discretion to provide certain manufacturers a pathway to market covered products that may not currently meet certain applicable requirements. Immediate implementation of the information collection is critical to providing predictability, stability, and continuity in the infant formula market, specifically with respect to products currently available to infants in the U.S. under FDA’s exercise of enforcement discretion. Because we believe that routine procedures allowing for a 60-day comment period would have prevented our ability to immediately implement the information collection, we requested a waiver from the requirement to publish notice in the Federal Register under 5 CFR 1320.13(a)(2)(iii).

US Code: 21 USC 301 et seq. Name of Law: Federal Food, Drug, and Cosmetic Act (FFDCA)
  
None

Not associated with rulemaking
Other Documents for OIRA Review

No

14
IC Title Form No. Form Name
Exempt Infant Formula Production; GMP; Audits, Records & Records
Exempt Infant Formula; Notification Requirements Form FDA 3978 Infant Formula Tracking System
IC in support of enforcement discretion
Infant Formula; Labeling (3rd Party Disclosure) Requirements
New Infant Formula Registration Form FDA 3978 Infant Formula Tracking System
New Infant Formula Submission Form FDA 3978 Infant Formula Tracking System
Notifications under 106.120(b) Form FDA 3978 Infant Formula Tracking System
Part 106; Subpart B - CGMP Requirements (records)
Part 107; Subpart C - Exempt Infant Formulas (records)
Recordkeeping under Part 106; Subparts C-G - quality control, audits, testing, records
Reports for exampt Infant Formula Form FDA 3978 Infant Formula Tracking System
Reports under FFDCA section 412(d) Form FDA 3978 Infant Formula Tracking System
Requirements for Quality Factors -- PER Exemption Form FDA 3978 Infant Formula Tracking System
Requirements for Quality Factors GMS Exemption Form FDA 3978 Infant Formula Tracking System

  Total Request Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 8,110 7,995 0 115 0 0
Annual Time Burden (Hours) 132,715 128,530 0 4,185 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
FDA is temporarily exercising enforcement discretion with respect to how respondents comply with applicable requirements, including adjustments to existing ways to comply with such requirements (see 5 CFR 1320.3(b)(1)(v)) to address an immediate threat to the public health resulting from the disruption in the supply of necessary products.

$272,773
No
    No
    No
No
No
No
No
Domini Bean 301 796-5733 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
09/28/2022


© 2024 OMB.report | Privacy Policy